Therapeutic Strategies for Parkinson’s Disease: The Ancient Meets the Future—Traditional Chinese Herbal Medicine, Electroacupuncture, Gene Therapy and Stem Cells
- 664 Downloads
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson’s disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine—herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson’s disease.
KeywordsParkinson’s disease Triptolide Electroacupuncture Gene therapy Stem cells
This study was supported by the National Basic Research Program of China (2006C B500700), National Natural Science Foundation of China (30430280, 30472245, 30571704 and 30500255) and Natural Science Foundation of Beijing (kz200510025014).
- 3.Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G (2006) Role of lifestyle factors on plasma homocysteine levels in Parkinson’s disease patients treated with levodopa. Nat Neurosci 9:11–16Google Scholar
- 8.Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, Ng JC, Kao PN (1999) Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin–2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 274:13443–13450PubMedCrossRefGoogle Scholar
- 15.Gu M, Zhou HF, Xue B, Niu DB, Wang XM (2004) The effect of Chinese Herb Tripterygium Wilfordii Hook F. Monomer T10 on in vitro model of Alzheimer’s disease. Acta Physiol Sin 56:73–78Google Scholar
- 22.Liang XB, Liu XY, Li FQ, Luo Y, Lu J, Zhang WM, Wang XM, Han JS (2002) Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res 108:51–59PubMedCrossRefGoogle Scholar
- 24.Qian ZN, Gu ZL, Pan JX (1985) The effect of acupuncture analgesia on the monamine transmitters in the rat striatum and spinal cord. Zhen Ci Yan Jiu 13:199–121Google Scholar
- 33.Mandel RJ, Spratt SK, Snyder RO, Leff SE (1997) Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats. Proc Natl Acad Sci USA 94:14083–14088PubMedCrossRefGoogle Scholar
- 38.Xu GH, Ling Y, Wan Y, Wang XM, Han JS (1998) Construction of recombinant adenovirus expressing human tyrosine hydroxylase gene and study of its activityes in vitro. Chinese J Neuroanatomy 14:313–317Google Scholar
- 39.Xu GH, Ling Y, Wan Y, Wang XM, Han JS (1999) Development of the recombinant GDNF-adenovirus and observation of its protective effects on primary cultured dopaminergic neurons against neurotoxin MPP+. Chinese J Biochem Mol Biol 15:42–47Google Scholar
- 47.Vescovi AL, Parati EA, Gritti A, Poulin P, Ferrario M, Wanke E, Frőlichsthal-Schoeller P, Cova L, Arcellana-Panlilio M, Colombo A, Galli A (1999) Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 156:71–88PubMedCrossRefGoogle Scholar
- 53.Carvey PM, Ling ZD, Sortwell CE, Pitzer MR, McGuire SO, Storch A, Collier TJ (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson’s disease. Exp Neurol 171:98–108PubMedCrossRefGoogle Scholar
- 60.Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115:102–109PubMedGoogle Scholar